Status:
ENROLLING_BY_INVITATION
To Explore the Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function After Simultaneous Pancreas-kidney Transplantation
Lead Sponsor:
Zhen Li
Conditions:
Simultaneous Pancreas-Kidney Transplantation
Eligibility:
All Genders
Brief Summary
Pancreatic kidney joint transplantation (SPK) has become the standard treatment for patients with diabetes complicated by end-stage renal disease. By simultaneously transplanting the pancreas and kidn...
Detailed Description
Pancreatic transplantation refers to the process of transplanting a healthy pancreas, either whole or in segments, from a donor into a recipient to restore endocrine function. Pancreatic transplantati...
Eligibility Criteria
Inclusion
- Patients who have undergone combined pancreas-kidney transplantation and are prescribed an MRI examination
- Age/Gender: No restrictions
- Patients who voluntarily participate in the clinical trial and sign a written informed consent form
Exclusion
- Patients with a pacemaker, unknown material implants, metal implants, neurostimulators, or claustrophobia 2.Patients who cannot tolerate sufficient breath-holding for a complete MRI examination
Key Trial Info
Start Date :
December 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 12 2030
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07001917
Start Date
December 20 2025
End Date
December 12 2030
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji hospital, NO.1095 jiefang avenue,
Wuhan, Hubei, China, 430074